-

Rob Ramirez Joins Inlightened as Head of Strategy

Pharma market research veteran and PBIRG President's Award winner to lead growth strategy for the healthcare insights platform

BOSTON--(BUSINESS WIRE)--Inlightened, the tech-enabled insights platform that connects client companies to a vetted network of healthcare professionals, today announced that Rob Ramirez has joined the company as head of strategy. Ramirez brings 30 years of experience in pharmaceutical market research, healthcare insights, and commercial strategy, including senior leadership roles at Pfizer, Ipsos Healthcare, Schlesinger Group (now Trivoca Health), and, most recently, Manifest Health.

Ramirez is a recognized leader in healthcare market research and a recipient of the Pharmaceutical Business Intelligence and Research Group (PBIRG) President's Award for his contributions to pharmaceutical research, as well as a finalist in Constellation Research's SuperNova Awards for his work advancing the use of collaboration technology in qualitative research. Throughout his career, he has helped pharma, biotech, and research agency clients translate complex healthcare data into commercial decisions.

At Inlightened, Ramirez leads the company's growth strategy and will shape how it serves market researchers, pharma insights teams, and research service providers. His focus includes deepening Inlightened's healthcare professional (HCP) and allied health recruitment offering, expanding service lines for clients running qualitative and quantitative healthcare research, and strengthening client experience as the platform scales.

“Inlightened has built something the industry needs: real relationships with vetted healthcare professionals, paired with the technology to recruit them at speed,” said Ramirez. “After three decades on both the pharma and the agency side, I know how hard it is to reach the right physicians, advanced practice providers, and industry professionals for serious research. That's exactly the problem Inlightened solves, and I'm here to help more researchers see what it can do for them.”

“Rob's reputation in pharma market research speaks for itself, and his client-side perspective is invaluable as we keep growing,” added Shelli Pavone, president and co-founder of Inlightened. “He knows our clients and understands what's at stake when business success depends on reaching the right healthcare experts. We're delighted to have him on the team.”

About Inlightened

Inlightened is the go-to SaaS platform for healthcare innovation. It connects client organizations to on-demand insights, via an unparalleled network of curated, vetted, and engaged experts. In addition to being recognized among Forbes’ Inaugural Next 1000, Inlightened has been featured in Crunchbase, Forbes, and MedCity News. Inlightened was acquired by LocumTenens.com, part of the Jackson Healthcare® family of companies, in August of 2023, and operates as an independent entity.

Learn more at www.getinlightened.com.

Contacts

For Media Inquiries, Contact:
Kristin Faulder (on behalf of Inlightened)
kfaulder@5by5agency.com
(586) 419-4652

Inlightened


Release Versions

Contacts

For Media Inquiries, Contact:
Kristin Faulder (on behalf of Inlightened)
kfaulder@5by5agency.com
(586) 419-4652

More News From Inlightened

New Survey Finds Healthcare Experts Fear AI Is the Next Frontier of Online Misinformation

BOSTON--(BUSINESS WIRE)--Inlightened, a tech-enabled insights platform that connects innovative client companies to a network of vetted healthcare professionals (HCPs), today announced the findings of a survey to measure experts’ feelings about the impact of online influence and mis/disinformation. The results reveal that key opinion leaders are not only worried about the impact of online medical misinformation for patients and consumers today, but anticipate that it will get worse over the nex...

Survey of America’s Doctors Reveals Biggest Opportunities, Current Gaps for AI

BOSTON--(BUSINESS WIRE)--Inlightened, a tech-enabled insights platform that connects innovative client companies to a network of vetted healthcare professionals (HCPs), today announced the findings of a survey of U.S. physicians regarding AI. The findings reveal current usage and benefits, in addition to unrealized opportunities for novel solutions. The findings More than half – 57% – are currently using AI tools at work, such as ambient listening/clinical documentation, billing, chatbots, and...
Back to Newsroom